Reply to Jon Mikel Inarritu, Daniele Castellani, and Jeremy YC Teoh's Letter to the Editor re: Agustina Bessa, Steven Maclennan, Deborah Enting, et al. Consensus in Bladder Cancer Research Priorities Between Patients and Healthcare Professionals Using a Four-stage Modified Delphi Method. Eur Urol 2019;76:260-1

Bessa Agustina; Maclennan Steven; Enting Deborah; Bryan Richard; Haggstrom Christel; Van Hemelrijck Mieke

首页> 外文期刊>European urology >Reply to Jon Mikel Inarritu, Daniele Castellani, and Jeremy YC Teoh's Letter to the Editor re: Agustina Bessa, Steven Maclennan, Deborah Enting, et al. Consensus in Bladder Cancer Research Priorities Between Patients and Healthcare Professionals Using a Four-stage Modified Delphi Method. Eur Urol 2019;76:260-1

【24h】

Reply to Jon Mikel Inarritu, Daniele Castellani, and Jeremy YC Teoh's Letter to the Editor re: Agustina Bessa, Steven Maclennan, Deborah Enting, et al. Consensus in Bladder Cancer Research Priorities Between Patients and Healthcare Professionals Using a Four-stage Modified Delphi Method. Eur Urol 2019;76:260-1

机译：回复Jon Mikel Inarritu，Daniele Castellani和Jeremy Yc Teoh给编辑的信Re：Agustina Bessa，Steven Maclennan，Deborah enting等，等等。使用四阶段改性德尔福法在膀胱癌研究优先事项中的膀胱癌研究优先事项。欧元乌尔尔2019; 76：260-1

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European urology》 |2019年第2期|共2页
作者
Bessa Agustina; Maclennan Steven; Enting Deborah; Bryan Richard; Haggstrom Christel; Van Hemelrijck Mieke;
展开▼
作者单位

Kings Coll London Sch Canc &

Pharmaceut Studies TOUR London England;

Univ Aberdeen Acad Urol Unit Aberdeen Scotland;

Kings Coll London Sch Canc &

Pharmaceut Studies TOUR London England;

Univ Birmingham Inst Canc &

Genom Sci Birmingham W Midlands England;

Umea Univ Umea Sweden;

Kings Coll London Sch Canc &

Pharmaceut Studies TOUR London England;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类泌尿科学（泌尿生殖系疾病）;
关键词

相似文献

外文文献

1. Reply to Jon Mikel Inarritu, Daniele Castellani, and Jeremy YC Teoh's Letter to the Editor re: Agustina Bessa, Steven Maclennan, Deborah Enting, et al. Consensus in Bladder Cancer Research Priorities Between Patients and Healthcare Professionals Using a Four-stage Modified Delphi Method. Eur Urol 2019;76:260-1 [J] . Bessa Agustina, Maclennan Steven, Enting Deborah, European urology . 2019,第2期

机译：回复Jon Mikel Inarritu，Daniele Castellani和Jeremy Yc Teoh给编辑的信Re：Agustina Bessa，Steven Maclennan，Deborah enting等，等等。使用四阶段改性德尔福法在膀胱癌研究优先事项中的膀胱癌研究优先事项。欧元乌尔尔2019; 76：260-1
2. Reply to Jeremy YC Teoh, Thomas RW Herrmann, and Marek Babjuk's Letter to the Editor re: Valeria Panebianco, Yoshifumi Narumi, Ersan Altun, et al. Multiparametric Magnetic Resonance Imaging for Bladder Cancer: Development of VI-RADS (Vesical Imaging-Reporting and Data System). Eur Urol 2018;74:294-306 [J] . Panebianco Valeria, Barentsz Jelle, Narumi Yoshifumi, European urology . 2019,第2期

机译：回复Jeremy Yc Teoh，Thomas Rw Herrmann和Marek Babjuk的信，Re：Valeria Panebianco，Yoshifumi Narumi，Ersan Altun等。用于膀胱癌的多射磁共振成像：VI-RADS的发展（血清血管成像报告和数据系统）。 EUR UROL 2018; 74：294-306
3. Reply to Xuefeng Liu's Letter to the Editor, re: Kimmo Kettunen, Peter J. Bostrom, Tarja Lamminen, et al. Personalized Drug Sensitivity Screening for Bladder Cancer Using Conditionally Reprogrammed Patient-derived Cells. Eur Urol 2019;76:430-4: Can Patient-derived Cancer Models Change the Costliest Cancer Type? [J] . Kettunen Kimmo, Bostrom Peter, Taimen Pekka European urology . 2020,第1期

机译：回复刘峰刘致编辑，Re：Kimmo Kettunen，Peter J. Bostrom，Tarja Lamminen，等。使用条件重编程患者衍生细胞的个性化药物敏感性筛选膀胱癌。 EUR UROL 2019; 76：430-4：患者衍生的癌症模型可以改变最昂贵的癌症类型吗？

著录项

相似文献

相关主题

期刊订阅